In this newsletter we talk about two of our investees:

  • Hatchtech and Dr. Reddy’s Laboratories sign US$197 million commercial  agreement for next generation head lice treatment
  • Uniseed investee ProGel Pty Ltd releases Perkii® probiotic drink.

 

uniseed-newsletter-sept2015

Save